Severe belly pain, a high fever, or heavy rectal bleeding need emergency care now. Call 911.
Crohn's disease is long-running inflammation that can affect any part of the digestive tract from the mouth to the anus, and it most often involves the last part of the small bowel and the beginning of the colon 1. Two features make it behave differently from other bowel conditions. First, the inflammation is patchy, so healthy segments can sit between inflamed ones. Second, it can run through the full thickness of the bowel wall rather than staying on the inner lining 2.
Those two features explain almost everything about how testing is done. Patchy involvement means a single biopsy from a single spot can miss it, so a clinician samples several segments. Full-thickness involvement means a camera that only sees the inner surface cannot show the whole picture, so cross-sectional scans are used to look at the wall itself and at what sits outside it.
Over time, inflammation in the wall can leave behind narrowing, and narrowed segments change what a person feels and what the right test is 3. Symptoms commonly include diarrhea that lasts for weeks, crampy belly pain, fatigue and unintended weight loss 1. None of those symptoms belong to one condition only, which is exactly why the testing sequence exists.
There is no stand-alone test that settles the question, so the answer is built from several sources that agree with each other. European consensus guidance describes diagnosis as resting on a combination of clinical history and examination, laboratory tests, endoscopy with tissue samples, and imaging, rather than on any one gold-standard result 4.
Think of it as four questions asked in order. Is there real inflammation in the gut, or are the symptoms coming from something that does not inflame the bowel wall? If there is inflammation, where is it and what does the lining look like under a microscope? How much of the small bowel is involved, and is the wall thickened or narrowed? And is anything happening around the anus that the colonoscope cannot reach?
Each layer has a blind spot that the next layer covers. Blood markers can be normal while the lining is inflamed. A colonoscope reaches the colon and usually the last few inches of small bowel, but not the long stretch above it. A scan shows the wall and what lies beyond it, but cannot replace a tissue sample. That redundancy is deliberate, and it is why testing can feel slow. Each step narrows the list rather than announcing an answer.
This matters practically. A normal result early in the sequence does not always end the process, and an abnormal one rarely ends it either. What it does is tell the clinician which test is worth doing next.
Testing is usually triggered by digestive symptoms that have run for weeks rather than days, especially diarrhea, crampy belly pain, blood in the stool, unintended weight loss and persistent fatigue 1. A few patterns tend to move a clinician faster. Symptoms that wake a person from sleep, stools that change in a way that does not track with diet or stress, and weight that falls without trying all raise the priority of looking properly.
It is worth being honest about how common these symptoms are and how often they come from something else entirely. Changes in stool frequency have a long list of ordinary explanations, and most people with loose or frequent stools do not turn out to have inflammatory bowel disease. The frequent bowel movements causes guide walks through that wider list, from infections and dietary triggers to thyroid and stress-related patterns.
Some symptoms sit outside the gut and still belong in the conversation. Joint aches, mouth sores, eye irritation and skin changes can accompany bowel inflammation 2. Pain, swelling or drainage around the anus deserves specific mention to the clinician, because that area is examined differently from the rest of the bowel.
The practical move is not to self-sort symptoms into a diagnosis. It is to bring a clear timeline. How many weeks, how many stools, any blood, how much weight, what makes it better or worse, and what medicines are in the picture. That timeline shapes which test comes first.
A stool test for inflammation shows whether white blood cells are actively moving into the bowel wall and lining, which helps separate inflammatory bowel symptoms from non-inflammatory ones. Fecal calprotectin is the marker used most often, and American gastroenterology guideline work supports the use of stool and blood biomarkers in assessing people with Crohn's disease rather than relying on symptoms alone 5. The fecal calprotectin test guide covers what the marker is and how a result is read.
Its value is mostly in sorting. A low result in someone with mild, long-standing symptoms makes active bowel inflammation less likely and can spare an unnecessary scope. A raised result does not name the cause, because inflammation in the gut has several sources, but it does justify looking inside. Research suggests that calprotectin levels track with inflammation visible at endoscopy, which is why the marker is used both before diagnosis and during follow-up 5.
Stool testing usually includes a check for infection at the same time. Consensus guidance recommends stool testing for infectious causes, including Clostridioides difficile, when inflammatory bowel disease is suspected or when symptoms flare, because an infection can mimic or sit on top of inflammation 4.
Practical notes matter here. A sample collected on a day of unusually loose stool, a sample left sitting before it reaches the lab, or recent use of some medicines can shift the number. Ask your prescriber before changing anything you take, and ask the lab how to collect and store the sample.
Hemoglobin is the oxygen-carrying protein in red blood cells, and it is one of the first numbers a clinician checks when digestive symptoms have been running for weeks. It can drift down when blood is lost slowly from the gut or when iron and other building blocks are absorbed poorly, and anemia is one of the common findings in people with Crohn's disease 1.
A low value does not name its own cause. It is a prompt to look further, usually with iron markers and a stool test for inflammation. The biomarker guide covers what the value measures, how it is tested and how to read a result in more depth.
Blood work in this setting is a screen for the consequences of inflammation and poor absorption, not a test for Crohn's disease itself. A typical first round includes a complete blood count, iron markers including ferritin, inflammatory markers such as C-reactive protein, albumin, kidney and liver markers, and vitamin B12 and folate, since the part of the small bowel most often involved is where B12 is absorbed 1. Guideline work supports C-reactive protein as one of the blood markers used alongside stool testing when assessing disease activity 5.
| Marker | Lab reference range | FitScript optimal range |
|---|---|---|
| Hemoglobin (men) | As printed on your lab report | 14 to 16 g/dL |
| Hemoglobin (women) | As printed on your lab report | 12 to 15 g/dL |
| Creatinine (men) | As printed on your lab report | Standard range only |
| Creatinine (women) | As printed on your lab report | Standard range only |
Compare your result with the range printed on your lab report. Ranges vary by laboratory, age and sex. FitScript's optimal ranges are optimization targets, not diagnostic cut-offs, and they do not replace what a clinician concludes from the whole picture.
C-reactive protein, ferritin and B12 are reported in different units by different laboratories, so they are described here in words rather than numbers. The pattern that draws attention is a cluster, such as a falling blood count with low iron stores and a raised inflammatory marker, rather than any single value. FitScript's membership covers 150+ biomarkers tested per year with interpretation by Atlas, FitScript's AI health advisor, and any treatment decision belongs to a licensed provider.
One caution worth keeping. Blood markers can look unremarkable while the lining is clearly inflamed, so a clean panel is reassurance, not clearance.
Antibody tests do not confirm or exclude Crohn's disease on their own, and they are not used as the deciding step. Anti-Saccharomyces cerevisiae antibodies, usually shortened to ASCA, are among the serologic markers that have been studied in inflammatory bowel disease, and European consensus guidance does not recommend routine serologic testing for diagnosis 4. The asca test guide explains what the antibody is and how a result is reported.
The reason is a matter of arithmetic rather than opinion. A test that is often negative in people who do have the condition, and sometimes positive in people who do not, cannot carry a diagnosis by itself. Where these markers occasionally help is at the margins, such as when the pattern of colonic inflammation is hard to classify, and even then the result is weighed against endoscopy and tissue findings rather than above them.
This comes up often because direct-to-consumer panels sometimes include antibody markers and present them as a shortcut. They are not a shortcut. A positive antibody result with no symptoms and no inflammation on stool testing usually changes nothing about what happens next, and a negative result in someone with weeks of bloody diarrhea changes nothing either.
If an antibody result is already in hand, bring it to the appointment. It becomes one more input, interpreted next to the stool marker, the blood count and whatever the scope and scan show.
Colonoscopy with biopsies is the step that usually establishes the diagnosis, because it combines a direct view of the lining with tissue that a pathologist examines under a microscope. Consensus guidance describes ileocolonoscopy with biopsies taken from the last part of the small bowel and from each segment of the colon as the first-line procedure when Crohn's disease is suspected 4. Multiple samples are taken even from segments that look normal, because the inflammation is patchy and microscopic changes can hide under a normal-looking surface.
The day before involves a cleansing preparation that empties the colon, usually a liquid regimen with a clear-fluid diet. The procedure itself is done with sedation, takes under an hour in most cases, and the camera is passed through the colon and, where possible, a short way into the last part of the small bowel. That final stretch matters, because it is the segment most often involved 1.
The operator records what the lining looks like, including ulcers, their shape and distribution, and whether segments of normal lining separate inflamed ones 2. Those visual features, combined with the pathology report, carry most of the diagnostic weight.
Two add-ons come up. An upper endoscopy is considered when symptoms point to the stomach or upper small bowel. A capsule endoscopy, a swallowed camera that photographs the small bowel, is sometimes used when the suspicion remains high after a normal colonoscopy, though it is avoided where narrowing is suspected because the capsule can lodge 4.
MR and CT enterography are used to see the parts of the small bowel a colonoscope cannot reach and to assess the bowel wall itself rather than only its inner surface. These are dedicated protocols in which the bowel is distended with oral scan preparations so that the wall can be measured and assessed, and published imaging guidance describes the findings they are read for, including wall thickening, increased wall enhancement, layered wall appearance, narrowed segments with upstream dilation, and tracts that extend beyond the wall 6.
That list is the practical point of the scan. Endoscopy answers what the lining looks like. Enterography answers how much bowel is involved, how thick and inflamed the wall is, whether a segment has narrowed, and whether anything has tracked outside the bowel. Those answers change management in a way a scope alone cannot.
MR enterography uses no ionizing radiation, which matters when scans are likely to be repeated over years, and it gives detailed soft-tissue information. CT enterography is faster and more widely available, and it is often the one used when a person is acutely unwell and an answer is needed quickly 6.
Narrowing deserves its own mention. International consensus work on fibrostenosing small bowel Crohn's disease describes cross-sectional imaging as central to identifying and characterizing narrowed segments, since the balance of active inflammation and scarring in a stricture influences what is done about it 3.
Expect the appointment to involve drinking a volume of preparation over an hour or so before the scan, and expect some bloating afterwards. Tell the imaging team about kidney problems, previous reactions to scan preparations, and any implanted devices before the appointment.
Bowel ultrasound adds a radiation-free, repeatable look at the bowel wall that can be done in the clinic room, often in the same visit. Specialized techniques, including small intestine contrast ultrasonography and contrast-enhanced ultrasound, have been described for assessing the small bowel in Crohn's disease, and studies suggest these methods can assess wall thickening and help identify complications such as narrowed segments, tracts and collections 7.
Its strengths and limits are both about practicality. Because there is no radiation, no sedation and little preparation, it can be repeated as often as the clinical question demands, which suits follow-up more than one-off diagnosis. Its weakness is that it is operator-dependent and harder in deeper parts of the abdomen, so availability and expertise vary a great deal between centres.
In practice, ultrasound tends to sit alongside the other tests rather than replacing them. It can answer a focused question quickly, such as whether a thickened segment looks different from last visit, while MR or CT enterography remains the detailed map and endoscopy remains the source of tissue.
If ultrasound is offered, it is reasonable to ask what question it is being used to answer and whether a cross-sectional scan is still planned.
The area around the anus is examined separately, because tracts, abscesses and fissures there are not visible from inside the bowel and are assessed with a combination of physical examination, pelvic MRI and, in some centres, examination under anesthesia or endoanal ultrasound. A systematic review and expert consensus on isolated perianal Crohn's disease describes this combined approach and sets out diagnostic criteria for cases where perianal involvement exists without inflammation elsewhere in the bowel 8.
This is the part of the workup most often delayed, usually because the symptoms feel embarrassing to raise. Pain on sitting, a lump near the anus, drainage onto underwear, or a small opening in the skin that weeps are all worth describing plainly to a clinician. Research suggests that perianal involvement can be present without luminal bowel disease, which is why it is recognised as a distinct pattern rather than an afterthought 8.
Pelvic MRI is the imaging usually used here, because it maps the path of a tract in relation to the muscles that control continence. That map matters for whatever is decided afterwards, and those decisions belong to a clinician, usually a gastroenterologist working with a colorectal surgeon.
If anal pain comes with fever or rapidly increasing swelling, that is a reason to seek care the same day rather than waiting for a scheduled appointment.
Several conditions produce weeks of diarrhea and belly pain without being Crohn's disease, which is why the first layer of testing is designed to sort rather than to confirm. Infections are the most common alternative, and stool testing for infectious causes is part of the standard assessment 4. Irritable bowel syndrome produces persistent symptoms without inflammation in the bowel wall, which is where a normal stool inflammation marker is genuinely useful.
Celiac disease, microscopic colitis and ulcerative colitis also sit on the list. Separating Crohn's disease from ulcerative colitis rests on the pattern of inflammation, since ulcerative colitis involves the colon continuously from the rectum upwards while Crohn's disease can be patchy and can involve any part of the tract 2. That distinction is drawn from endoscopy, biopsies and imaging together, not from a blood test.
Some medicines can cause or worsen diarrhea and can irritate the bowel lining. If a new medicine lines up with the start of symptoms, mention it and ask your prescriber rather than stopping anything on your own.
The general principle holds. Symptoms point at a category, tests narrow the category, and tissue and imaging settle what the category actually is. A clinician makes that call, not a lab value and not a symptom checklist.
Several ordinary things shift these results, and knowing them prevents a repeat test or a wrong turn. Stool markers are sensitive to sample handling, so a sample collected unevenly, stored warm or delayed on its way to the lab can read differently from the same stool handled properly. Ask the laboratory for its specific instructions and follow them exactly.
Recent gut infections raise inflammation markers in the stool without any long-term bowel condition being present, which is one reason stool infection testing is done at the same time. Bleeding from a source other than the bowel, such as heavy periods in women or a recent nosebleed, can lower a blood count for reasons that have nothing to do with the gut.
Some medicines change both stool markers and blood counts. Do not stop or start anything to make a test look cleaner, and ask your prescriber what to do about anything you take before a scheduled test.
On the imaging side, an incomplete bowel preparation before colonoscopy limits the view and sometimes forces a repeat. Not drinking the full volume of scan preparation before enterography leaves bowel loops collapsed, and a collapsed loop can imitate a thickened wall or hide a real one 6. The unglamorous part of the preparation is the part that determines whether the scan is readable.
After a diagnosis is made, testing shifts from identification to monitoring, and the balance moves towards less invasive tools used more often. American guideline work supports using stool and blood biomarkers, alongside symptoms, to assess disease activity and to guide when more invasive assessment is needed in people with Crohn's disease 5. Repeat biomarker testing may help decide when a scope or a scan is warranted rather than booking either on a fixed schedule 5.
The reason symptoms alone are not enough is that they and inflammation do not always move together. A person can feel reasonably well while the lining remains inflamed, and can feel awful from a narrowed segment that is more scar than active inflammation. That mismatch is why an objective marker sits next to the symptom diary.
Scans stay in the picture for structural questions. Where narrowing is known or suspected, consensus guidance describes cross-sectional imaging as the way to characterize the segment over time 3. Bowel ultrasound, where expertise exists, offers a quick repeat look without radiation 7.
Blood work keeps earning its place too, since anemia and low iron can recur quietly and often show up before a person notices fatigue 1. Tracking the same markers on the same schedule makes the trend readable, which is worth more than any single reading.
Talk to a clinician when digestive symptoms have lasted more than a few weeks, when there is blood in the stool, when weight is falling without trying, or when fatigue is out of proportion to everything else. Those are the circumstances in which the testing sequence described here is worth starting, and the sooner the sequence starts the fewer rounds it usually takes.
Some situations need prompt attention rather than a scheduled appointment. Severe belly pain, a high fever, heavy rectal bleeding, persistent vomiting with an inability to keep fluids down, or rapidly increasing pain and swelling near the anus should be seen urgently, and the first three on that list mean emergency care now.
If you already have results, bring the actual reports rather than a summary from memory, including the units and the lab's printed reference range. A result outside the standard range is worth discussing with a clinician promptly, and no abnormal result should be ignored or explained away without a professional look at it.
This page is educational and is not medical advice. Discuss your results, your symptoms and any treatment with a clinician or licensed provider, who decides what testing and what management are appropriate for you.
No. Blood work shows the consequences of inflammation and poor absorption, such as a low blood count or low iron, but it cannot confirm the condition on its own. A clinician combines blood results with stool testing, a colonoscopy with biopsies and imaging before reaching a conclusion.
Most workups start with a stool test for inflammation plus a stool check for infection, alongside basic blood work. These are quick, non-invasive and good at sorting inflammatory from non-inflammatory causes. What they show decides whether a colonoscopy and a scan come next.
Not by itself, though it makes active bowel inflammation less likely. If symptoms are persistent or severe, a clinician may still proceed to endoscopy or imaging. Discuss a normal result in the context of your full symptom history rather than treating it as a final answer.
The clinic provides a cleansing preparation to take the day before, usually with a clear-fluid diet. Finishing the full preparation matters, because an incomplete clean-out limits the view and can force a repeat. Ask your prescriber about anything you take regularly before the appointment.
Both use oral scan preparations to open out the small bowel so the wall can be assessed. MR uses no ionizing radiation, which suits repeated scans over years, while CT is faster and more widely available, so it is often chosen when an answer is needed quickly. Your clinician picks based on the question and what is available.
It is not used as the deciding test, so a result in isolation rarely changes what happens next. A positive result without symptoms or inflammation usually means little, and a negative result does not clear someone with ongoing symptoms. If you already have one, bring it to the appointment as one more input.
It depends on access to endoscopy and imaging in your area and on how quickly earlier results come back, so no fixed timeline applies. Stool and blood results typically return first, with scheduled procedures following. Ask the clinic for its current booking times rather than planning around an estimate.
Bring the actual report, including units and the printed reference range, to a clinician and discuss it promptly. A single value outside a range is a prompt to look further, not a conclusion. Do not ignore it, and do not change anything you take without speaking to your prescriber.